1/27
Looks like no tags are added yet.
Learning Objectives
List impact of alcohol on other medical and psychiatric disorders
Recognize screening tools used in alcohol use disorder and alcohol withdrawal
Describe symptoms and timeline of alcohol withdrawal
Summarize treatment strategies (including medication, target symptoms, routes of admin) for acute withdrawal and prevention of complications (BZDs vs MVI, Folate, Thiamine)
Classify severity of alcohol use disorder based on DSM5
Compare FDA approved medications for AUD
Select treatment strategies
Some conditions that Alcohol can impact or worsen
Heartburn
Suicide ideation
Hypertension
Insomnia, anxiety
additive CNS depression
How much alcohol in ALCOHOL types
12 oz beer - 5%
8-9 oz malt liquor - 7%
Wine - 12%
Gin, rum, tequila, vodka — 40%
What is a good screening tool for alcohol?
CAGE questionnaire
scores of > 2 signify potential problem
DSM-5 criteria for Alcohol Withdrawal
Cessation (or reduction in) prolonged and heavy use of alcohol AND
2 or more of the following symptoms within hours to days of alcohol cessation/reduction
Autonomic hyperactivity
Hand/tremor
Insomnia
N/V
Hallucinations
Psychomotor agitation
Anxiety
Seizuers
Who is AT RISK for Alcohol withdrawal ?
History of alcohol WD delirium or WD seizures
numerous WD episodes
Co-morbid medical or surgical illness
Age >65 years
Long duration of regular/heavy alcohol consumption
Seizures during current episodes
Presenting with autonomic hyperactivity
Physiological dependence on BZDs or barbiturates
Who MAY be at RISK for Alcohol withdrawal ?
use of other substances of misuse
Positive Blood alcohol level (BAL) with symptoms of WD
Co-occurring psychiatric disorder
Easy to understand pathophysiology of alcohol intoxication
Increased GABA + alcohol activity
Less glutamate activity
Pathophysiology of alcohol WITHDRAWAL
Unregulated receptors of glutamate INCREASED due to consistent GABA depression
More glutamate activity as a REBOUND once alcohol is stopped —- withdrawal symptoms
Timeline of alcohol withdrawal
6 to 36 hours - tremors, anxiety, GI upset - mental status normal
6 to 72 hours - seizures risk (1/3 seizures will become Delirium tremens)
12 to 48 hours - halluconosis, visual, auditory, tactile - resolves within 24-48 hours
48 to 72/96 hours - Delirium Tremens
If Delirium Tremens is UNTREATED — Wernickes Encephalopathy
If WE untreated ——— 80-90% progress to Korsakoff Psychosis
Points about Delirium tremens
Extreme hyperactivity of the autonomic nervous system
Altered mental status, hallucinations, tachycardia, HTN, hyperthermia, agitation
Life threatening
Seizures points relating to AWD
Tonic clonic seiures
90% of alcohol withdrawal related seizures occur within 48 hours after last drink
Likelihood of seizures increases with the number of past withdrawals
Life threatening
Points about Wernicke-Korsakoff
related to thiamine deficiency
Severe cognitive impairment, delirium, gait, disorientiation, paralysis of certain eye muscles
Can leave patients with Korsakoff syndrome which is characterized by abnormal gaze, ataxia, disabling memory disorder, psychosis
What is in a Banana Bag?
Thiamine, Magnesium, Folic acid, Vitamins
Withdrawal assessment (CIWA Ar) points
N/V
Tremor
Paroxysmal sweating
Anxiety
Agitation
Tactile disturbances
Visual disturbances
Auditory disturbances
Headache
Orientation
Score of <8 = mild
score of 8-14 = moderate
score of >15 = severe
What is used to treat Alcohol withdrawal Syndrome?
benzodiazepines or barbiturates
Librium
diazepam
lorazepam
KNOW THESE 3^^^!!!
still good to know the class of BZDs as well
and remember that Lorazepam, Oxazepam, and Temazepam can only be used in liver impairment (important for alcohol disorders)
Order that we should use/choose medications for Alcohol Withdrawal symptoms
Benzodiazepines
Barbiturates
Goals of treatment in AWD
Prevent severe withdrawal
Prevent DTs
Non-pharmt treatments for Alcohol USE disorder (not
CBT
Short term residential programs
outpatient treatment
Alcoholics Anonymous
Goals of treatment for AUD
Decrease number of days drinking
Decrease number of days with heavy drinking
Decrease # of drinks per day
Minimize physical, psychological financial and social harm
The TWO agents for first line AUD treatment pharmacologically
Naltrexone
Acamprosate
Naltrexone points for AUD
MOA: Opioid Antagonist
Use in AUD: Reduce craving goal to reduce heavy drinking // Reduce reward
Adverse effects: Nausea, sedation, pain at injection site (IM)
Considerations: Caution in hepatic impairment “benefit often outweighs risk in hepatic impairment” '// abstinence is NOT required // contraindicated with opioids
Acamprosate points for AUD
MOA: Glutamate Modulator
Use in AUD: Maintain abstinence, reduce cravings
Adverse effects: GI Adverse effects
Considerations: Requires renal dosage adjustment // Works better if patient has completed alcohol withdrawal
Some important points about Naltrexone formulations for AUD
2 peak concentrations
initial peak - 2 hours after injection
2nd peak 2-3 days later
~14 days after dosing concentrations slowly decline
Measurable levels > 1 month
Naltrexone is NOT metabolized by the CYP system, so there are lower incidences of DDIs
Second and third line options for AUD treatment
Disulfiram
Gabapentin
Topiramate
Disulfiram points in treatment of AUD
2nd/3rd line
Use in AUD: Aversive “negative” reinforcement —- AVOID DRINKING!!!
Adverse effects: Facial flushing, N/V, HA, dizziness/palps/tachy — monitor LFTs
Cannot drink with other Alcoholic agents - caution in hepatic disease
Gabapentin points in treatment of AUD
2nd/3rd line
Use in AUD: Cravings
Adverse effects: CNS sedation/dizziness
Considerations: Comorbidities - used for anxiety // neuropathic pain —- renal dose adjustment
Topiramate points in treatment of AUD (off label)
2nd/3rd line
Use in AUD: Cravings
Adverse effects: Cognitive slowing // kidney stones // Paresthesias
Considerations: Comorbidities - PTSD [1st comorbidity] !!!! // migraine // cocaine use DO —- renal dose adjustment
Main lecture takeaways
Alcohol withdrawal symptoms can range from severe to mold ad can be deadly (peaking within 3-5 days)
Preferred management strategy includes symptom triggered dosing utilizing benzodiazepines
Supportive care includes: multivitamins, thiamine, folic acid, in addition to electrolytes and fluids as needed
FDA approved meds for AUD include naltrexone, acamprosate, and disulfiram
Future directions - GLP1s